Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Norwegian council rejects routine breast cancer screening

This article was originally published in Clinica

Executive Summary

Despite recent figures from the Norwegian cancer registry indicating that the number of breast cancer cases was still on the increase, the National Council for Prioritising in the Health Service (NCPHS) last week said that it saw no reason to prioritise routine mammography in the health budget. The council is not convinced that screening would be either cost effective or medically justifiable. "There are other ways to use this money that will be more effective in solving basic problems in the health service," said Magne Holme, director of the council.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel